Generally speaking and on a wide array of pressing issues, Congressman Darrell Issa (R – California…
CFIF on Twitter CFIF on YouTube
Potential Appointment of Rep. Darrell Issa to IP Subcommittee Leadership Raises Concern

Generally speaking and on a wide array of pressing issues, Congressman Darrell Issa (R – California) has proven a reliable leader who maintains solid support among conservatives and libertarians.

The prospect of Rep. Issa leading the House Judiciary Committee’s Courts, Intellectual Property, and the Internet Subcommittee, however, has sparked significant opposition and pushback from intellectual property (IP) proponents.  And for sound reasons.

For example, in urging new House Judiciary Committee Chairman Jim Jordan (R – Ohio) not to select Rep. Issa for the role, IPWatchdog’s Paul Morinville lists a litany of concerns based upon Issa’s record:

Issa is the wrong person for the job and has demonstrated that since he joined Congress.  He has sponsored and cosponsored…[more]

January 23, 2023 • 10:13 AM

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
Jester's Courtroom Legal tales stranger than stranger than fiction: Ridiculous and sometimes funny lawsuits plaguing our courts
Home Press Room CFIF Opposes H.R. 3, Pelosi’s Socialized Medicine Bill
CFIF Opposes H.R. 3, Pelosi’s Socialized Medicine Bill Print
Friday, September 20 2019

ALEXANDRIA, VA – This week, Speaker of the House Nancy Pelosi (D - California) introduced H.R. 3, her long-anticipated, hyper-partisan scheme to impose a socialized drug pricing system and reorder American medical care to her liking.  In response, Center for Individual Freedom ("CFIF") President Jeffrey Mazzella issued the following statement: 

"CFIF unambiguously opposes Nancy Pelosi’s legislation, which amounts to the worst and most far-reaching attempt yet witnessed to impose government control over Americans’ healthcare access. 

"Pelosi’s proposal includes such mechanisms as foreign price controls, compulsory arbitration with government bureaucrats, a complete restructuring the popular Medicare Part D program and what amounts to a retroactive 95% tax on hundreds of the most commonly-used medicines in America.  As CFIF has long highlighted, America enjoys – by far – the most innovative pharmaceutical industry in the world, accounting for two-thirds of all new lifesaving and life-improving drugs globally.  But by importing price controls from foreign nations – which ignore drug patents to extort compliance – to America rather than exporting our more effective free market policies to their shores, American consumers would begin suffering the same drawbacks that consumers in those nations do.  Namely, unavailability of those critical lifesaving and life-improving drugs. 

"As even the United Nations World Health Organization (WHO) acknowledges, price controls suffocate innovation and delay the arrival of new drugs, or deny them entirely.  It’s therefore no accident that nations imposing price controls enjoy a fraction of the new pharmaceuticals that Americans access, and that America outpaces those countries in terms of cancer survival rates and other benefits.  Pelosi’s bill would also jeopardize nearly $1 trillion of pharmaceutical investment, research and development. 

"All of this is far too high a price for Americans to pay on behalf of Nancy Pelosi’s socialized medicine pet project.  CFIF therefore opposes her proposed legislation in the strongest terms, applauds Members of Congress who have already voiced opposition to it and encourages all Americans to contact their Representatives and Senators to express their opposition as well."

CFIF is a constitutional and free market advocacy organization with over 300,000 supporters and activists nationwide. 

###

 

Quiz Question   
In what year did Congress pass the Uniform Monday Holiday Bill?
More Questions
Notable Quote   
 
"Just about everyone in America has an opinion on how the Centers for Disease Control (CDC) handled the COVID pandemic response -- and these opinions often follow political lines. However, trust in the agency is low among Americans of all political stripes, and even Director Rochelle Walensky has acknowledged that the CDC has failed to 'reliably meet expectations.'A lack of public confidence in the…[more]
 
 
—Havilah Wingfield, Visiting Fellow at Independent Women’s Forum and Fellow with Health Reformers Academy
— Havilah Wingfield, Visiting Fellow at Independent Women’s Forum and Fellow with Health Reformers Academy
 
Liberty Poll   

Although early in Kevin McCarthy's tenure as House Speaker, how would you grade him on his performance thus far?